SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000048
Filing Date
2024-02-14
Accepted
2024-02-14 16:55:35
Documents
64
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20231231x10q.htm   iXBRL 10-Q 1295037
2 EX-31.1 nnvc-20231231xex31d1.htm EX-31.1 11892
3 EX-31.2 nnvc-20231231xex31d2.htm EX-31.2 12408
4 EX-32.1 nnvc-20231231xex32d1.htm EX-32.1 7760
5 EX-32.2 nnvc-20231231xex32d2.htm EX-32.2 7339
  Complete submission text file 0001410578-24-000048.txt   5253974

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20231231.xsd EX-101.SCH 41441
7 EX-101.CAL nnvc-20231231_cal.xml EX-101.CAL 28947
8 EX-101.DEF nnvc-20231231_def.xml EX-101.DEF 159132
9 EX-101.LAB nnvc-20231231_lab.xml EX-101.LAB 315082
10 EX-101.PRE nnvc-20231231_pre.xml EX-101.PRE 232260
66 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20231231x10q_htm.xml XML 819519
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 24639916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)